LIFEMD, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
LIFEMD, INC. (LFMD) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $15.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-05
- LIFEMD, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $7.08M, a 135.53% increase year-over-year.
- LIFEMD, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $8.87M, a 439.25% increase year-over-year.
- LIFEMD, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was $3.01M.
- LIFEMD, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was $1.65M.
- LIFEMD, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $10.23M, a 55.85% decline from fiscal 2024.
- LIFEMD, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $23.18M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.96M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $8.87M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $10.23M 10-K · filed 2026-03-10 | |||
| 2025-06-30 | $3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.65M 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $1.65M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $23.18M 10-K · filed 2026-03-10 | |||
| 2016-09-30 | -$217.70K 10-Q · filed 2017-11-14 | -$482.24K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |